Literature DB >> 20691172

A multi-target screening analysis in human plasma using fast liquid chromatography-hybrid tandem mass spectrometry (Part I).

V Viette1, D Guillarme, R Mylonas, Y Mauron, M Fathi, S Rudaz, D Hochstrasser, J-L Veuthey.   

Abstract

OBJECTIVES: Evaluate a new LC-MS/MS screening method for drugs and drugs of abuse as an alternative to the existing methods used in clinical toxicology laboratories. DESIGN AND METHODS: The work was divided in two parts. The first part was dedicated to the technical development and evaluation of the method for which a set of 97 drugs and relevant metabolites was used to perform a complete investigation of matrix effects and lower limit of identification (LOI). The second part was a comparison of identified drugs between LC-MS/MS and Remedi® instrument on clinical serum samples.
RESULTS: The method offers good performance allowing an automatic peak detection and compound identification. The limit of identification is equivalent to 50 μg/L for the majority of the studied compounds. The process efficiency (PE) is higher than 70% for 65% of the evaluated compounds. Thus, a sufficient detection capability in terms of limit of detection for identification and PE satisfied the expected performance.
CONCLUSION: The described methodology allows the identification of the main drugs incriminated in intoxications within a quite short analysis time. The separation of most of the analytes is performed in 15 min. The procedure is sufficiently sensitive and selective. Copyright Â
© 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691172     DOI: 10.1016/j.clinbiochem.2010.07.021

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Post-acquisition data processing for the screening of transformation products of different organic contaminants. Two-year monitoring of river water using LC-ESI-QTOF-MS and GCxGC-EI-TOF-MS.

Authors:  S Herrera López; M M Ulaszewska; M D Hernando; M J Martínez Bueno; M J Gómez; A R Fernández-Alba
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-22       Impact factor: 4.223

2.  Metabolite identification and quantitation in LC-MS/MS-based metabolomics.

Authors:  Jun Feng Xiao; Bin Zhou; Habtom W Ressom
Journal:  Trends Analyt Chem       Date:  2012-02-01       Impact factor: 12.296

3.  Hair-based rapid analyses for multiple drugs in forensics and doping: application of dynamic multiple reaction monitoring with LC-MS/MS.

Authors:  Iltaf Shah; Andrea Petroczi; Martina Uvacsek; Márta Ránky; Declan P Naughton
Journal:  Chem Cent J       Date:  2014-12-13       Impact factor: 4.215

4.  Chromatographic behavior of co-eluted plasma compounds and effect on screening of drugs by APCI-LC-MS(/MS): Applications to selected cardiovascular drugs.

Authors:  Yahya R Tahboub
Journal:  J Pharm Anal       Date:  2014-07-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.